Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Liver & Bile Duct (All Stages^), 2018-2022

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)1


Wyoming2


Vermont2


Nebraska2


North Dakota2


New Hampshire2


South Dakota2


Utah7


Maine2


Colorado2


Kansas2


Montana2


Michigan2


Iowa7


Nevada2


Wisconsin2


Virginia2


Idaho7


Ohio2


Puerto Rico2


Arizona2


New Jersey7


South Carolina2


Minnesota2


Connecticut7


New York7


Indiana2


Illinois7


Delaware2


Pennsylvania2


West Virginia2


Florida2


Massachusetts2


Maryland2


Missouri2


Tennessee2


Georgia7


Alabama2


Rhode Island2


Washington1


Mississippi2


Oregon2


Arkansas2


North Carolina2


Hawaii7


Kentucky7


Oklahoma2


Alaska2


California7


New Mexico7


Louisiana7


District of Columbia2


Texas7





Notes:
Created by statecancerprofiles.cancer.gov on 03/21/2026 6:16 pm.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.